NDC 64038-620 - Cyclo/Mag 10mg/200mg
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 64038-620
- Package NDCs from labels
- 64038-620-03
- Manufacturer
- Living Well Pharmacy, Inc. | Apotheca Supply | Spectrum Laboratory Products, Inc.
- Effective date
- 2010-02-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CYCLO/MAG KIT | Living Well Pharmacy, Inc. | Apotheca Supply | Spectrum Laboratory Products, Inc. | 2010-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64038-620-03 | Cyclo/Mag 10mg/200mg | 3 g in 1 BOTTLE | POWDER | 3 g | 1 g in 1g | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CYCLOBENZAPRINE HYDROCHLORIDE | ACTIVE INGREDIENT | 0VE05JYS2P | CYCLO/MAG 10MG/200MG (CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM OXIDE) KIT [LIVING WELL PHARMACY, INC.] | 1 | |
| MAGNESIUM OXIDE | ACTIVE INGREDIENT | 3A3U0GI71G | CYCLO/MAG 10MG/200MG (CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM OXIDE) KIT [LIVING WELL PHARMACY, INC.] | 1 | |
| CYCLOBENZAPRINE | ACTIVE MOIETY | 69O5WQQ5TI | CYCLO/MAG 10MG/200MG (CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM OXIDE) KIT [LIVING WELL PHARMACY, INC.] | 1 | |
| MAGNESIUM OXIDE | ACTIVE MOIETY | 3A3U0GI71G | CYCLO/MAG 10MG/200MG (CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM OXIDE) KIT [LIVING WELL PHARMACY, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Aurobindo Pharma Limited | 1154688c-1383-442b-a3a5-ec01e038795c | 2021-11-09 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Proficient Rx LP | f14bc532-e30f-490f-b97b-d0dab9a2ba0c | 2021-10-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 0280b504-4a42-44f3-8a1a-34a20eac054a | 2021-05-26 | Warnings, Adverse reactions | 0VE05JYS2P |
| Magnesium Oxide | MAGNESIUM OXIDE | Par Health | d5c123f8-1396-4d8c-96d3-e5ade96a6ef8 | 2020-11-10 | Warnings | 3A3U0GI71G |
| Magnesium Oxide | MAGNESIUM OXIDE | Par Health | d3c5b01b-f0d6-4503-ab18-b1a72386e2c6 | 2020-06-03 | Warnings | 3A3U0GI71G |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | bb23383c-087a-4fb1-8917-edecd1ec4527 | 2020-06-03 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | be5201bc-e1f1-41af-be46-4a8fbb223b86 | 2020-05-27 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Proficient Rx LP | 50aa421f-1d73-4b43-8528-2617ef2507dc | 2019-12-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Proficient Rx LP | 571fbb2b-24e0-4de3-8cfa-c267fc397b6c | 2019-10-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Magnesium Oxide 400mg | MAGNESIUM OXIDE 400MG | Allegiant Health | 2ea68874-8c20-4284-bd0a-f07768057b83 | 2019-01-28 | Warnings | 3A3U0GI71G |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | KVK-TECH, Inc. | 5b756c04-e7b8-4efe-815a-3f3e020727fb | 2018-12-19 | Warnings, Adverse reactions | 0VE05JYS2P |
| Magnesium Oxide | MAGNESIUM OXIDE | Aphena Pharma Solutions - Tennessee, LLC | 11b2ce71-61fd-4e75-a859-a260b1dda080 | 2018-11-07 | Warnings | 3A3U0GI71G |
| Magnesium Oxide | MAGNESIUM OXIDE | Aphena Pharma Solutions - Tennessee, LLC | edabc9e4-60ad-407f-97c8-dfec5ee7eeb1 | 2018-10-25 | Warnings | 3A3U0GI71G |
| 38c7d64b-ee76-4d72-b3d0-6d05eb5aa2a3 | c2b6213c-3397-42cf-8080-59d6a5c31d0a | 2010-02-17 | Warnings | 38c7d64b-ee76-4d72-b3d0-6d05eb5aa2a3 c2b6213c-3397-42cf-8080-59d6a5c31d0a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.